Eisai Company, Limited

Eisai R&d Management Co., Ltd.

Ono Pharmaceutical Co., Ltd.

Mercian Corporation and Eisai Co., Ltd.

Taro Semba

Yasuhiro Funahashi

Takashi Owa

Toshiaki Wakabayashi

Norihiro Ueda

Akihiko Tsuruoka

Keiko Takahashi

Yuji Yamamoto

Tadashi Okabe

Toru Haneda

Kazumasa Nara

Yoichi Ozawa

Junichi Kamata

Shinichi Hamaoka

Naoko Hata

Noako Tsukahara

Takuya Suzuki

Yoshio Watanabe

Junji Matsui

Kazuyuki Dobashi

Tomohiro Sameshima

Masanori Fujita

Atsumi Yamaguchi

Naoko Tsukahara

Tadashi Kadowaki

Yusuke Adachi

Yusuke Narita

Nobuaki Naruse

Rena Kawase

Kazuhiko Yamada

Kentaro Takahashi

A combined administration of a liposomal composition comprising Eribulin or a pharmaceutically acceptable salt thereof and a PD-1 antagonist exhibits unexpected antitumor effect.

Pharmaceutical composition for treating tumor

Disclosed herein is a method for treating tumor, comprising administering a liposomal composition comprising eribulin or a pharmaceutically acceptable salt thereof and a PD-1 antagonist to a patient in need thereof.

The present invention relates to pharmaceutical compositions comprising a sulfonamide-including compound in combination with an angiogenesis inhibitor.

Use of sulfonamide-including compounds in combination with angiogenesis inhibitors

The present invention provides an integrin expression inhibitor, and an agent for treating arterial sclerosis, psoriasis, cancer, retinal angiogenesis, diabetic retinopathy or inflammatory diseases, an anticoagulant, or a cancer metastasis suppressor on the basis of an integrin inhibitory action. Namely, it provides an integrin expression inhibitor comprising, as an active ingredient, a sulfonamide compound represented by the following formula (I), a pharmacologically acceptable salt thereof or a hydrate of them, wherein in the formula, B means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated; K means a single bond, &#x2014;CH&#x2550;CH&#x2014; or &#x2014;(CRR)&#x2014; (wherein Rand Rare the same as or different from each other and each means hydrogen atom or a C1-C4 alkyl group; and mmeans an integer of 1 or 2); Rmeans hydrogen atom or a C1-C6 alkyl group; Z means a single bond or &#x2014;CO&#x2014;NH&#x2014;; and R means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated, respectively.

Integrin expression inhibitor

Sulfonamide-containing heterocyclic compounds

Sulfonamide-containing indole compounds

Physiologically active substances

Growing community of inventors

Ibaraki, Japan

Taro Semba